Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating aT-catenin phosphorylation and downstream signaling pathways in the cardiomyocyte

FY 2022-23

Summary
Heart failure is a debilitating condition affecting millions of people worldwide. Understanding the molecular mechanisms of heart failure is crucial for developing effective therapies. Our lab has identified a region in the protein ?T-catenin (CTNNA3) that is highly phosphorylated in the heart muscle cells of heart failure patients with dilated cardiomyopathy. The enzymes responsible for CTNNA3 phosphorylation and the downstream signaling pathways involved remain largely unknown. Identifying drugs that can alter CTNNA3 phosphorylation in order to activate cardio-protective signaling may reveal new ways to improve cardiac function in the failing heart. For this study, I will first use computational and literature-based methods to predict the enzymes that may target CTNNA3, then enhance/inhibit these enzymes in CTNNA3-expressing cells using existing drugs to determine which ones affect phosphorylation. Second, using both a viral gene transfer strategy as well as the drug candidates identified above, I will overexpress modified forms of the CTNNA3 protein in mice wherein the protein is either normal, cannot be phosphorylated, or mimics phosphorylation, and then induce an experimental model of heart disease to determine the effects on heart function. Thirdly, to characterize the underlying mechanisms of cardio-protection, I will investigate the localization of downstream signaling molecules, YAP, ?-catenin, and CTNNA3 itself, in heart tissues and cells from these mice and assess changes to cardiac cell growth and contractile function. Ultimately, understanding the mechanisms of how CTNNA3 phosphorylation can benefit cardiac function will provide insight into methods for improving outcomes in patients with heart disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486532
Name
Davoudpour Daniel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating aT-catenin phosphorylation and downstream signaling pathways in the cardiomyocyte
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models; At-Catenin; Bioinformatics; Cardiac Repair; Cardiovascular Disease; Heart Failure; Hippo/Yap Pathway; Mass Spectrometry; Phosphoproteomics
Abstract
Heart failure is a debilitating condition affecting millions of people worldwide. Understanding the molecular mechanisms of heart failure is crucial for developing effective therapies. Our lab has identified a region in the protein ?T-catenin (CTNNA3) that is highly phosphorylated in the heart muscle cells of heart failure patients with dilated cardiomyopathy. The enzymes responsible for CTNNA3 phosphorylation and the downstream signaling pathways involved remain largely unknown. Identifying drugs that can alter CTNNA3 phosphorylation in order to activate cardio-protective signaling may reveal new ways to improve cardiac function in the failing heart. For this study, I will first use computational and literature-based methods to predict the enzymes that may target CTNNA3, then enhance/inhibit these enzymes in CTNNA3-expressing cells using existing drugs to determine which ones affect phosphorylation. Second, using both a viral gene transfer strategy as well as the drug candidates identified above, I will overexpress modified forms of the CTNNA3 protein in mice wherein the protein is either normal, cannot be phosphorylated, or mimics phosphorylation, and then induce an experimental model of heart disease to determine the effects on heart function. Thirdly, to characterize the underlying mechanisms of cardio-protection, I will investigate the localization of downstream signaling molecules, YAP, ?-catenin, and CTNNA3 itself, in heart tissues and cells from these mice and assess changes to cardiac cell growth and contractile function. Ultimately, understanding the mechanisms of how CTNNA3 phosphorylation can benefit cardiac function will provide insight into methods for improving outcomes in patients with heart disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Davoudpour, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~